Comparative pharmacokinetics of an adalimumab biosimilar SB5 administered via autoinjector or prefilled syringe in healthy subjects
Donghoon Shin,1 Younju Lee,1 Deokyoon Jeong,1 Rod Ellis-Pegler2 1Samsung Bioepis Co. Ltd, Incheon, Republic of Korea; 2Auckland Clinical Studies, Ltd., Auckland, New Zealand Purpose: The objective of this study was to demonstrate comparable pharmacokinetic (PK), safety, and tolerability parameters o...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , |
|---|---|
| Fformat: | Llyfr |
| Cyhoeddwyd: |
Dove Medical Press,
2018-11-01T00:00:00Z.
|
| Pynciau: | |
| Mynediad Ar-lein: | Connect to this object online. |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Rhyngrwyd
Connect to this object online.3rd Floor Main Library
| Rhif Galw: |
A1234.567 |
|---|---|
| Copi 1 | Ar gael |